Futura Medical PLC Notice of Preliminary Results (8147R)
March 05 2019 - 2:02AM
UK Regulatory
TIDMFUM
RNS Number : 8147R
Futura Medical PLC
05 March 2019
Notice of Preliminary Results
05 March 2019
Futura Medical plc (AIM: FUM) (the "Company"), a pharmaceutical
company developing a portfolio of innovative products for sexual
health and pain relief, will announce its preliminary results for
the year ended 31 December 2018 on Wednesday 10 April 2019.
James Barder, Chief Executive Officer, and Angela Hildreth,
Finance Director/Chief Operating Officer, will host a presentation
for analysts at 10am BST on the day of the results at the office of
N+1 Singer at 1 Bartholomew Lane, London EC2N 2AX.
A copy of the announcement will be made available on the Futura
Medical website and following the results meeting a webcast of the
presentation to analysts will also be made available within the
Investor Centre section of the site.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
Nominated Adviser and Broker:
N+1 Singer
Aubrey Powell/ Ben Farrow (Corporate Finance)
Mia Gardner/ Tom Salvesen (Corporate Broking)
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Hollie Vile/ Ellie Blackwell
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
Notes to editors:
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) drug delivery technology.
These products are optimised for clinical efficacy, safety,
administration and patient convenience and are developed for the
prescription and consumer healthcare markets as appropriate.
Current therapeutic areas are sexual health, including erectile
dysfunction, and pain relief. Development and commercialisation
strategies are designed to maximise product differentiation and
value creation whilst minimising risk.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORKMGGFZDMGLZZ
(END) Dow Jones Newswires
March 05, 2019 02:02 ET (07:02 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2023 to Apr 2024